GEICO: Antonio González, Clínica Universidad de Navarra, Madrid, Spain
ESMO: Andrés Cervantes, University Hospital, INCLIVA, Valencia, Spain
Chairs:
Ignacio Romero, Fundación Instituto Valenciano de Oncología, Valencia, Spain
Andrés Poveda, Initia Oncology, Hospital Quironsalud, Valencia, Spain
08:45 - 09:25Biomarkers in Ovarian Cancer: To be or not to be
Michael Birrer, Massachusetts General Hospital, Boston (MA), USA
Chairs:
Michael Birrer
Massachusetts General Hospital, Boston (MA), USA
Jose A López-Guerrero
Fundación Instituto Valenciano de Oncología, Valencia, Spain
09:25 - 09:45Precision Medicine in epithelial ovarian cancer
Iain McNeish
Imperial College London, UK
09:45 - 10:05The potential role of liquid biopsies in ovarian cancer
Martin Widschwendter
University College London Hospital, London, UK
10:05 - 10:25TILs and PD-L1 expression in ovarian cancer: What to do with it?
George Coukos
University of Lausanne, Switzerland
10:25 - 10:45Discussion
All
Chairs:
Jonathan A. Ledermann
University College London Cancer Institute, London, UK
Luis Chiva
Clínica Universidad de Navarra, Madrid, Spain
11:15 - 11:35How to manage lymph nodes in ovarian cancer in 2019
Philipp Harter
Kliniken Essen-Mitte, Essen, Germany
11:35 - 11:55Can we predict who lives long with ovarian cancer?
Michael A. Bookman
Arizona Oncology and US Oncology Research, Tucson (AZ), USA
11:55 - 12:15Landscape of systemic therapy for ovarian cancer in 2019
Keiichi Fujiwara
Saitama Medical University, Saitama, Japan
12:15 - 12:35Discussion
All
12:35 - 13:35Does HIPEC improve survival in AOC?
Chair:
Jan B. Vermorken
Antwerp University Hospital, Edegem, Belgium
Giovanni Scambia
Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy
PRO:
Gabe Sonke
Netherlands Cancer Institute, Amsterdam, Netherland
CONS:
Ignace Vergote
University Hospital Leuven, Belgium
13:15 - 13:35Discussion
All
Chairs:
Eric Pujade-Lauraine
Hôpital Hotel-Dieu, Paris, France
Ana Oaknin
Vall d’Hebron Institute of Oncology, Barcelona, Spain
15:00 - 15:20Who needs surgery?
Jalid Sehouli
Charité University of Medicine, Berlin, Germany
15:20 - 15:40Do all patients need systemic therapy?
Michael Friedlander
The Prince of Wales Hospital, Randwick, Australia
15:40 - 16:10Landscape of systemic therapy for recurrent ovarian cancer in 2019
Sandro Pignata
National Cancer Institute, Naples, Italy
16:10 - 16:30Discussion
All
Chairs:
Mansoor Mirza
Copenhagen University Hospital, Copenhagen, Denmark
Andres Redondo
Hospital Universitario La Paz, Madrid, Spain
17:00 - 17:20Immunotherapy in Ovarian Cancer: Still promising?
Antonio González
Clínica Universidad de Navarra, Madrid, Spain
17:20 - 17:40New Strategies in Ovarian Cancer Treatment
Elise C. Kohn
National Cancer Institute, Bethesda (MD), USA
Andrés Poveda
Initia Oncology, Hospital Quironsalud, Valencia, Spain